03 February 2013

Leica Biosystems establishes R&D facility in Boston, Massachusetts

- Leica is headquartered in Nussloch, Germany

Newcastle, U.K./Cambridge, Mass. – 01 February 2013 – Leica Biosystems has announced the establishment of its R&D facility in Massachusetts, in operation since August 2012. Leica’s presence in Massachusetts will focus on research and development of companion diagnostics. The company’s temporary offices and R&D lab space are in Danvers, Mass., but the Leica Biosystems team has plans to expand by the end of 2013. 

The main focus of the Leica Biosystems presence in Massachusetts is to support the pharmaceutical industry through development of targeted companion diagnostic tests. The company is headquartered in Nussloch, Germany, with operations also in the U.K., Australia, China, Singapore and Illinois

“We are delighted to announce the opening of the Leica Biosystems R&D facility in Boston,” said Matthias Weber, M.D., President of Leica Biosystems. “Being in Massachusetts gives us the ability to collaborate closely with the pharmaceutical industry on a domestic level, and this was a major influence in choosing Boston as our U.S. R&D location. We are already seeing the benefit of our decision, and look forward to our second round of recruitment in 2013.” 

Thanks to our growth strategy of investing in education, innovation and infrastructure, Massachusetts continues to lead the world in life sciences,” said Governor Deval Patrick. “We welcome Leica Biosystems to the Commonwealth and look forward to them creating jobs and economic opportunities here in Massachusetts.” 

Through the Massachusetts Life Sciences Center, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, proposed by Governor Patrick in 2007, and passed by the State Legislature and signed into law by Governor Patrick in 2008. 

“With its cutting-edge cancer diagnostics technology and processes for histology and tissue processing, Leica Biosystems will be an important partner for the Commonwealth’s R&D-focused organizations in both industry and academia,” said Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center.

Massachusetts has become the destination for the world’s most innovative companies across the entire life sciences spectrum,” said Robert K. Coughlin, President & CEO of MassBio, a 600+ member life sciences trade association. “We are thrilled to welcome Leica Biosystems and know they will play a very important role in our world-class life sciences ecosystem.” 

Leica Biosystems is a global leader in workflow solutions and automation, striving to advance cancer diagnostics to improve patients’ lives. It has manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. 

Source: Massachusetts Life Sciences Center